Rocket Lab is rated a strong buy with a $128.56 price target and 72% potential upside, driven by both organic growth and acquisitions like Iridium. The company’s vertical integration is nearly complete, enabling it to offer full satellite solutions and boosting competitiveness. Recent government contracts worth over $1 billion validate its strategy pivot towards defense markets. EBITDA margins are expected to reach 33% as development costs ease, with positive free cash flow anticipated by 2029 and long-term growth prospects beyond that.
Rocket Lab reported $234 million in revenue for Q2, with a backlog rising to $2.36 billion, driven by its Space Systems segment which accounted for 81% of revenue. The company aims to price its Neutron rocket between $50 million and $55 million witho...
ARK Invest, led by Cathie Wood, purchased 705,102 shares of Rocket Lab during a recent stock decline, viewing the dip as a buying opportunity. Rocket Lab, valued at around $38 billion, is a smaller public rival to SpaceX, focusing on small-satellite ...
SpaceX's stock currently trades below its first closing price despite a strong IPO debut, with a consensus analyst target price about 48% higher than the current price. Raymond James analyst Brian Gesuale projects a much more optimistic outlook, sett...
Rocket Lab is recognized for its strong execution in the aerospace sector, consistently beating analyst estimates for eight quarters. However, its stock trades at a high forward Price to Sales ratio of 40x, a significant premium over the sector media...
SpaceX shares rose 7% as investors anticipate the upcoming Starship test 14, the largest fully reusable rocket flight. Tesla also gained 7%, boosted by its ties to SpaceX and optimism around autonomy and manufacturing collaborations like the Terafab ...
